US2021061965A1PendingUtilityA1
Packaging material and methods of using the same
Assignee: UNIV NEW YORK STATE RES FOUNDPriority: May 23, 2017Filed: Sep 30, 2020Published: Mar 4, 2021
Est. expiryMay 23, 2037(~10.8 yrs left)· nominal 20-yr term from priority
C08K 5/07C08L 2203/16B65D 81/28B65B 25/001C08J 2367/04B65B 25/02B65B 25/062B32B 2307/7163C08K 5/175B65B 25/041C08K 5/0058B65D 81/24C08K 5/0025B32B 2379/00B65B 25/04A01N 25/10C08K 5/13B65B 25/067B32B 2367/00C08L 67/04C08K 5/053C08K 5/375C08K 5/1545B32B 2439/80A01N 37/24G01N 33/02C08L 79/08B65D 65/466C08J 2379/08C08J 3/24C08J 5/18
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure is directed to films. The films can include polyamic acid (PAA). Methods of making and using the film for food product coverings is also included.
Claims
exact text as granted — not AI-modified1 .- 37 . (canceled)
38 . A film comprising:
polyamic acid (PAA); glutaraldehyde (GA); and one or more molecule selected from the group consisting of alanine (A), tryptophan (W), 2-benzoylbenzoyl (BB), Polycaprolactone (PCl), L-Cysteine (C), D-glucosamine (DA), dipropylene glycol (DP), p-aminobenzoic acid (pAB), L-isoleucine (I), p-aminosalicylic acid (pAS), sulfanilic acid (SA), and 5-aminosalicylic acid (5AS).
39 . The film of claim 38 , wherein the one or more molecule is selected from the group consisting of sulfanilic acid (SA), p-aminosalicylic acid (pAS) and 5-aminosalicylic acid (5AS).
40 . The film of claim 38 , wherein the one or more molecule is selected from the group consisting of alanine (A), tryptophan (W), 2-benzylbenzoyl (BB), L-Cysteine (C), D-glucosamine (DA), dipropylene glycol (DP), p-aminobenzoic acid (pAB), L-isoleucine (I), p-aminosalicylic acid (pAS), and 5-aminosalicylic acid (5AS).
41 . The film of claim 38 , wherein the film has a thickness of about 0.02 mm to about 0.12 mm.
42 . The film of claim 38 , wherein the film has a modulus of elasticity of about 2.2 GPa to about 4.1 GPa.
43 . The film of claim 38 , wherein the film has a tensile strength of about 59.9 MPa to about 95.1 MPa.
44 . The film of claim 38 , wherein the film has an antibacterial activity of reducing the number of colony forming units (CFUs) by up to about 90%.
45 . The film of claim 44 , wherein the antibacterial activity against one or more of gram-positive and gram-negative bacterial species.
46 . The film of claim 45 , wherein the gram-positive species is Staphylococcus epidermidis and Listeria monocytogenes.
47 . The film of claim 45 , wherein the gram-negative species is one or more of Escherichia coli, Enterobacter aerogenes, Aeromonas hydrophila , and Citrobacter freundii.
48 . The film of claim 38 , wherein the film is synthesized from a solvent and does not include any petrochemical material.
49 . The film of claim 38 , wherein the solvent is ethanol.
50 . The film of claim 38 , wherein the film further comprises water.
51 . The film of claim 38 , wherein the film further comprises acetic acid.
52 . The film of claim 38 , wherein the concentration of GA is between about 0.21% and about 0.35%.
53 . The film of claim 38 , further comprising one or more of an adipate, a phthalate, a citrate and chitosan.
54 . The film of claim 38 , further comprising one or more of an oleic acid, a palmitoleic acid, a sapienic acid, a linoleic acid, a nitrile, a polychloroprene, a chlorinated polyethylene, an epichlorohydrin, a sabacate, a terephthalate, a gluterate, and an azelate.
55 . A film comprising:
polyamic acid (PAA); a cross-linker; and a small molecule, wherein the small molecule is a molecule having a molecular weight of less than about 900 Daltons.
56 . The film of claim 55 , wherein the cross-linker comprises one or more of glutaraldehyde and carbodiimidazole.
57 . The film of claim 55 , wherein the small molecule is one or more molecules selected from the group consisting of sulfanilic acid (SA), p-aminosalicylic acid (pAS) and 5-aminosalicylic acid (5AS).
58 . The film of claim 55 , wherein the small molecule is one or more molecules selected from the group consisting of alanine (A), tryptophan (W), 2-benzylbenzoyl (BB), L-Cysteine (C), D-glucosamine (DA), dipropylene glycol (DP), p-aminobenzoic acid (pAB), L-isoleucine (I), p-aminosalicylic acid (pAS), 5-aminosalicylic acid (5AS).
59 . The film of claim 55 , wherein the small molecule is one or more molecules selected from the group consisting of alanine (A), tryptophan (W), 2-benzylbenzoyl (BB), Polycaprolactone(PCl), L-Cysteine (C), D-glucosamine (DA), dipropylene glycol (DP), p-aminobenzoic acid (pAB), L-isoleucine (I), p-aminosalicylic acid (pAS), sulfanilic acid (SA), 5-aminosalicylic acid (5AS).
60 . The film of claim 55 , wherein the film further comprises water.
61 . The film of claim 55 , wherein the film further comprises acetic acid.Join the waitlist — get patent alerts
Track US2021061965A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.